C5AR1 and ovarian carcinoma: Thus, in the present study, by combined analysis of human and mouse ovarian cancer (OC) samples, we defined C5aR as a molecular switch that controls TAM antitumor activity and investigated its underlying mechanisms; in addition, we evaluated the promising role of C5aR blockade in cancer immunotherapy.